41 results
8-K/A
EX-99.2
QNCX
Quince Therapeutics Inc
5 Jan 24
Independent Auditors’ Report
4:01pm
;
Level 3: Inputs that are unobservable. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level
8-K/A
EX-99.1
2ga f4wekccv1
5 Jan 24
Independent Auditors’ Report
4:01pm
8-K/A
EX-99.3
yc4alu26t1lmtzi
5 Jan 24
Independent Auditors’ Report
4:01pm
8-K
EX-2.1
d417jq1b
24 Jul 23
Entry into a Material Definitive Agreement
7:16am
424B5
tth 130d53zfp0ylk47g
19 May 22
Prospectus supplement for primary offering
4:44pm
8-K
EX-2.1
fpoard
12 May 22
Entry into a Material Definitive Agreement
5:12pm
POS AM
7bg uautnd
4 Mar 22
Prospectus update (post-effective amendment)
4:04pm
POSASR
1emo7 jei9h9e07xg25
7 Feb 22
Automatic shelf registration (post-effective amendment)
5:01pm
424B5
sqnf7
23 Dec 21
Prospectus supplement for primary offering
5:24pm